Welcome to OM Pharma
Immunostimulant - Immunotherapy
Broncho-Vaxom® : Chronic bronchitis - Chronic obstructive pulmonary disease
  Philosophy
  History
  Worldwide activity
  R & D
  Manufacturing
  Products
    Marketing Authorizations
    International Availability
  Main Products
    - Broncho-Vaxom
    - Dicynone
    - Doxium
    - Uro-Vaxom
    Other Products
    - Doxiproct
    - Doxiproct Plus
    - Gynazole
    - Sinomarin
  Health and Diseases
  News
  Contacts
  Careers and jobs
  Forum


  homepage > products broncho-vaxom > properties/effects
   
  Broncho-Vaxom
 
Properties/Effects

Immunostimulating agent
In animals, an increased resistance towards experimental infections, a stimulation of macrophages and B lymphocytes as well as an increase in immunoglobulins secreted by the respiratory mucosal cells have been reported.

In humans, an increase in the rate of circulating T lymphocytes, in salivary IgA, in the non-specific response to polyclonal mitogens and in the mixed lymphocyte reaction have been observed.

Preclinical safety data
Extensive toxicity studies have not revealed any toxic effect.
  Contact us   back home